Stay updated on ANIMATE: Nivolumab in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the ANIMATE: Nivolumab in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ANIMATE: Nivolumab in Hodgkin Lymphoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The ClinicalTrials.gov study page no longer displays the embedded 403 error markup in its main content area. The site revision label changes from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-01T16:34:40.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A notice appears at the top of the page announcing NIH website transition updates and stating that some content may use “Super Intelligence” instead of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T15:48:26.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-18T22:20:27.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T22:18:40.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error with a minimal header/footer instead of the study details. This indicates an access issue rather than a content update to the study record.
    Difference
    19%
    Check dated 2026-09-20T22:29:35.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The page adds a U.S. NIH Grant/Contract funding note and updates the page revision to v3.6.6 (replacing the previous v3.6.5).
    Difference
    0.1%
    Check dated 2026-08-30T18:51:54.000Z thumbnail image

Stay in the know with updates to ANIMATE: Nivolumab in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ANIMATE: Nivolumab in Hodgkin Lymphoma Clinical Trial page.